RESECTABLE HEPATOCELLULAR CARCINOMA
Clinical trials for RESECTABLE HEPATOCELLULAR CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RESECTABLE HEPATOCELLULAR CARCINOMA trials appear
Sign up with your email to follow new studies for RESECTABLE HEPATOCELLULAR CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo before liver surgery shows promise in early trial
Disease control OngoingThis phase II trial is testing whether giving two drugs—atezolizumab (an immunotherapy) and bevacizumab (which blocks blood vessel growth)—before surgery can help prevent liver cancer from returning. The study enrolled 16 adults with resectable liver cancer. The main goals are to…
Matched conditions: RESECTABLE HEPATOCELLULAR CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
Liver cancer patients get Pre-Surgery combo: radiation plus immunotherapy shows promise
Disease control OngoingThis study tests whether giving a short course of targeted radiation (SBRT) along with two immunotherapy drugs (atezolizumab and bevacizumab) before surgery is safe and effective for people with liver cancer that can be removed. About 20 participants will receive this combination…
Matched conditions: RESECTABLE HEPATOCELLULAR CARCINOMA
Phase: EARLY_PHASE1 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New PET tracer could sharpen liver cancer diagnosis before surgery
Diagnosis OngoingThis study is testing a new imaging agent called 18F-FSPG to see if it can better detect liver cancer (hepatocellular carcinoma) and other liver tumors compared to standard PET scans. About 110 adults with liver cancer or benign liver tumors will receive the tracer before their s…
Matched conditions: RESECTABLE HEPATOCELLULAR CARCINOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Diagnosis
Last updated Jun 27, 2026 13:00 UTC
-
New blood test aims to catch liver cancer recurrence early
Diagnosis OngoingThis study is testing a new blood test that looks for DNA changes to detect if liver cancer has come back or spread after surgery. Researchers at Mayo Clinic are enrolling 36 patients with early-stage liver cancer who are scheduled for surgery. The goal is to see if this test can…
Matched conditions: RESECTABLE HEPATOCELLULAR CARCINOMA
Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Jun 27, 2026 12:23 UTC